ImmunityBio (IBRX) is up 25.3%, or $1.40 to $6.92.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBRX:
- Morning Movers: Fastenal and 3M slip following quarterly results
- Video: Stocks point lower as Greenland tensions reach boiling point
- ImmunityBio: Accelerating ANKTIVA Commercial Traction and Global Regulatory Momentum Support Buy Rating
- ImmunityBio price target raised to $7 from $5 at Piper Sandler
- ImmunityBio provides update on Type B meeting with FDA on Anktiva pathway